Maxime Dely: How Plasma Exchange Treats Severe Diseases – “A Simple Act Behind a Complex Therapy”
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Plasma: the invisible therapy that’s already transforming modern medicine!
Plasma exchanges play a crucial role today in treating many severe conditions. Performed using apheresis, they remove harmful components from the patient’s plasma… a highly technical procedure with often remarkable results.
And for this therapy to exist, one key element is essential: albumin.
A protein available exclusively thanks to plasma donations. Without donors, plasma exchanges simply cannot happen.
A major therapeutic tool
Plasma exchanges are used to treat:
• Autoimmune diseases (myasthenia gravis, Guillain-Barré syndrome…)
• Hematological disorders
• Severe neurological conditions
• Kidney diseases
• Complex immunological disorders
This technique removes autoantibodies, toxins or immune complexes that drive the disease.
Looking ahead: incredible new prospects
Recent studies suggest that plasma exchanges may slow the progression of Alzheimer’s disease, opening the door to new approaches for neurodegenerative conditions.
A promising field that could reshape the future of care for millions of patients.
A simple act behind a complex therapy
Plasma exchanges require large amounts of albumin.
Albumin comes only from plasma donors.
Every donation makes these treatments possible.
A heartfelt thank you to all donors: your generosity saves lives every single day.”

Get the latest from Hemostasis Today.
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: 3 Oral Presentations, 2 Posters, Many Inspiring Discussions – EHA 2026
-
Jun 15, 2026, 10:32Magnus Ek: 17,000 Delegates, 150 Staff, 1 Massive Success – EHA 2026!
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable
-
Jun 15, 2026, 10:07Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026